Zacks Company Profile for QuidelOrtho Corporation (QDEL : NSDQ) |
|
|
|
Company Description |
QuidelOrtho is a provider of rapid diagnostic testing solutions, cellular-based virology assays and molecular diagnostic systems. The company's brand names include Sofia(R), Solana(R), Lyra(R), Triage(R) and QuickVue(R). Its comprehensive product portfolio includes tests for a range of infectious diseases, cardiac and autoimmune biomarkers, as well as a host of products to detect COVID-19. QuidelOrtho, formerly known as Quidel Corporation, is based in SAN DIEGO.
Number of Employees: 6,600 |
|
|
|
Price / Volume Information |
Yesterday's Closing Price: $36.34 |
Daily Weekly Monthly
 |
20 Day Moving Average: 1,945,365 shares |
Shares Outstanding: 67.63 (millions) |
Market Capitalization: $2,457.52 (millions) |
Beta: 0.13 |
52 Week High: $49.45 |
52 Week Low: $23.77 |
Short Interest Ratio: |
|
% Price Change |
% Price Change Relative to S&P 500 |
4 Week |
35.04% |
27.97% |
12 Week |
-10.43% |
-3.23% |
Year To Date |
-18.43% |
-15.23% |
|
|
|
|
|
Address & Contact Information |
Street Address |
Phone / Fax |
Email Address |
Web URL |
9975 SUMMERS RIDGE ROAD - SAN DIEGO,CA 92121 USA |
ph: 858-552-1100 fax: 858-453-4338 |
ir@quidel.com |
http://www.quidelortho.com |
|
|
|
General Corporate Information |
Officers
Brian J. Blaser - Chief Executive Officer and President
Kenneth F. Buechler - Chairman
Joseph M. Busky - Chief Financial Officer
John R. Chiminski - Director
Evelyn S. Dilsaver - Director
|
|
Peer Information
QuidelOrtho Corporation (BJCT)
QuidelOrtho Corporation (CADMQ)
QuidelOrtho Corporation (APNO)
QuidelOrtho Corporation (UPDC)
QuidelOrtho Corporation (IMTIQ)
QuidelOrtho Corporation (CYGN)
|
|
Industry / Sector / Ticker Info
Analyst Coverage: No
Industry Group: MED PRODUCTS
Sector: Medical
CUSIP: 219798105
SIC: 2835
|
|
Fiscal Year
Fiscal Year End: December
Last Reported Quarter: 03/01/25
Next Expected EPS Date: 07/30/25
|
|
Share - Related Items
Shares Outstanding: 67.63
Most Recent Split Date: (:1)
Beta: 0.13
Market Capitalization: $2,457.52 (millions)
|
|
|
|
|
|
EPS Information |
Dividend Information |
Analyst Coverage: No |
Dividend Yield: 0.00% |
Current Fiscal Quarter EPS Consensus Estimate: $0.13 |
Indicated Annual Dividend: $0.00 |
Current Fiscal Year EPS Consensus Estimate: $2.25 |
Payout Ratio: 0.00 |
Number of Estimates in the Fiscal Year Consensus: 4.00 |
Change In Payout Ratio: 0.00 |
Estmated Long-Term EPS Growth Rate: % |
Last Dividend Paid: NA - $0.00 |
Next EPS Report Date: 07/30/25 |
|
|
|
|